The impact of adherence to osteoporosis therapy on fracture rates in actual practice

被引：0
|
作者：
Huybrechts, K
Naujoks, C
Ishak, K
Garfield, F
Caro, J
机构：
[1] Caro Res, Concord, MA USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B50
引用
收藏
页码：49S / 49S
页数：1
相关论文
共 50 条
  • [31] How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study
    Gonnelli, Stefano
    Caffarelli, Carla
    Rossi, Stefania
    Di Munno, Ombretta
    Malavolta, Nazzarena
    Isaia, Giancarlo
    Muratore, Maurizio
    D'Avola, Giovanni
    Gatto, Salvatore
    Minisola, Giovanni
    Nuti, Ranuccio
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (03) : 459 - 468
  • [32] RATE OF OSTEOPOROTIC FRACTURE OVER TIME AMONG WOMEN WITH AT LEAST ONE YEAR OF ADHERENCE TO OSTEOPOROSIS THERAPY
    Modi, Ankita
    Tang, Jackson
    Sen, Shuvayu
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S195 - S195
  • [33] ADHERENCE TO BISPHOSPHONATE THERAPY FOR POSTMENOPAUSAL OSTEOPOROSIS IN BULGARIA
    Kuzmanova, S. I.
    Solakov, P. T.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 374 - 374
  • [34] Improving adherence to and persistence with oral therapy of osteoporosis
    M. L. Bianchi
    P. Duca
    S. Vai
    G. Guglielmi
    R. Viti
    C. Battista
    A. Scillitani
    S. Muscarella
    G. Luisetto
    V. Camozzi
    R. Nuti
    C. Caffarelli
    S. Gonnelli
    C. Albanese
    V. De Tullio
    G. Isaia
    P. D’Amelio
    F. Broggi
    M. Croci
    Osteoporosis International, 2015, 26 : 1629 - 1638
  • [35] OSTEOPOROSIS THERAPY, BEYOND FRACTURE PREVENTION
    Adachi, J. D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S102 - S103
  • [36] How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study
    Stefano Gonnelli
    Carla Caffarelli
    Stefania Rossi
    Ombretta Di Munno
    Nazzarena Malavolta
    Giancarlo Isaia
    Maurizio Muratore
    Giovanni D’Avola
    Salvatore Gatto
    Giovanni Minisola
    Ranuccio Nuti
    Aging Clinical and Experimental Research, 2016, 28 : 459 - 468
  • [37] Adherence to bisphosphonate (BP) therapy for postmenopausal osteoporosis (PMO) is associated with a reduced risk of nonvertebral bone fracture
    Harris, S
    Silverman, S
    Siris, E
    Abbott, T
    Barr, C
    Rosen, C
    Geffen, D
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2005, 12 (06): : 799 - 799
  • [38] TRAINING FOR OSTEOPOROSIS CAREGIVERS INCREASES THERAPY ADHERENCE
    Polyakova, Y.
    Seewordova, L.
    Papichev, E.
    Akhverdyan, Y.
    Zavodovsky, B.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S525 - S526
  • [39] Improving adherence to and persistence with oral therapy of osteoporosis
    Bianchi, M. L.
    Duca, P.
    Vai, S.
    Guglielmi, G.
    Viti, R.
    Battista, C.
    Scillitani, A.
    Muscarella, S.
    Luisetto, G.
    Camozzi, V.
    Nuti, R.
    Caffarelli, C.
    Gonnelli, S.
    Albanese, C.
    De Tullio, V.
    Isaia, G.
    D'Amelio, P.
    Broggi, F.
    Croci, M.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (05) : 1629 - 1638
  • [40] Clinical and economic impact of adherence to osteoporosis medication
    Caro, JJ
    Ishak, KJ
    Huybrechts, KF
    Raggio, G
    Naujoks, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S2 - S3
12345